SCHEMBL7870352

SCHEMBL7870352

Cc1nc2cccc3n(CCCCCN4C(=O)c5ccccc5C4=O)c(=O)c1n23

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
HEXA P06865 1/20 0.40
HEXB P07686 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863477 1.00 ALDH1A1 (0.45) ALDH1A1HPGDGAAKMT2ASMN1; SMN2
SCHEMBL7863462 0.99 KMT2A (0.45) ALDH1A1HPGDGAAKMT2ASMN1; SMN2
SCHEMBL7870359 0.97 KMT2A (0.47) ALDH1A1HPGDGAAKMT2ASMN1; SMN2
SCHEMBL7871561 0.86 ALDH1A1 (0.36) ALDH1A1HPGDGAAKMT2ASMN1; SMN2
SCHEMBL7863446 0.82 HTT (0.39) TDP1HTTHEXAHEXB
SCHEMBL7863478 0.81 ALDH1A1 (0.48) ALDH1A1HPGDGAAKMT2ASMN1; SMN2
SCHEMBL7863487 0.76 HSD17B10 (0.49) ALDH1A1HPGDGAATSHRTDP1
Hydrochloric Acid SCHEMBL7871692 0.76 MEN1 (0.37) ALDH1A1KMT2ATDP1MEN1HTT
Hydrochloric Acid SCHEMBL7871546 0.76 TDP1 (0.41) ALDH1A1TDP1HTT
SCHEMBL7872436 0.75 ALDH1A1 (0.44) ALDH1A1GAASMN1; SMN2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010051631-A1 Tricyclic compounds, their production and use TAKATANI MUNEO (JP) 2001-12-13 US disclosed
US-6251905-B1 Tricyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-26 US disclosed
EP-0771319-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1997-05-07 EP disclosed
WO-1996002542-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051631-A1 Tricyclic compounds, their production and use PDGFA, HGF, REN ALDH1A1 2398/4885HPGD 1085/4885GAA 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.